Skip to main content

AI assistant

Sign in to chat with this filing

The assistant answers questions, extracts KPIs, and summarises risk factors directly from the filing text.

ABBOTT LABORATORIES Director's Dealing 2010

Feb 19, 2010

29777_dirs_2010-02-18_7d87a571-3196-4f2f-ab41-8741b65488a4.zip

Director's Dealing

Open in viewer

Opens in your device viewer

SEC Form 4 — Statement of Changes in Beneficial Ownership

Issuer: ABBOTT LABORATORIES (ABT)
CIK: 0000001800
Period of Report: 2010-02-16

Reporting Person: Landgraf John C (Senior Vice President)

Non-Derivative Transactions

Date Security Code Shares Price A/D Holdings After Ownership
2010-02-16 Common shares without par value F 5060 $53.9300 Disposed 79749 Direct
2010-02-16 Common shares without par value S 1700 $53.912 Disposed 78049 Direct
2010-02-17 Common shares without par value S 100 $54.8804 Disposed 77949 Direct
2010-02-17 Common shares without par value S 2100 $54.881 Disposed 75849 Direct
2010-02-17 Common shares without par value S 8040 $54.88 Disposed 67809 Direct

Holdings (Non-Derivative)

Security Shares Ownership
Common shares without par value 16401 Indirect
Common shares without par value 30000 Indirect
Common shares without par value 1602 Indirect

Footnotes

F1: Balance in the Abbott Laboratories Stock Retirement Trust as of February 15, 2010.

F2: Held in the Anne Marie Landgraf Living Trust. The reporting person and his spouse are co-trustees of the trust. The trust is revocable by his spouse.

F3: Includes shares acquired under the Abbott Laboratories Dividend Re-investment and Stock Purchase Plan in transactions exempt from Section 16 under Rule 16(a)-11.

F4: Reporting person disclaims beneficial ownership of all securities held by his son.